HK:2511 Stock Latest News
Company AnnouncementsHighTide Therapeutics Ends Concert Party Agreement, Founder Remains Largest Shareholder3d ago2511
Company AnnouncementsHighTide Therapeutics Grants Performance-Linked Share Options and Awards2M ago2511
Company AnnouncementsHighTide Therapeutics Highlights HTD1801 as Foundational CKM Therapy in Interim Results2M ago2511
Company AnnouncementsHighTide Therapeutics Sets Board Meeting to Approve Interim Results2M ago2511
Company AnnouncementsHighTide Therapeutics Raises HK$225 Million Through Share Placing to Fund HTD1801 Expansion2M ago2511
Company AnnouncementsHighTide Therapeutics Launches Discounted Share Placing to Raise HK$225 Million3M ago2511Company AnnouncementsHighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition3M ago2511
Company AnnouncementsHighTide Therapeutics Terminates Connected Loan After Regulatory Scrutiny4M ago2511
Company AnnouncementsHighTide Therapeutics Wins Strong Shareholder Backing at 2026 AGM4M ago2511
Company AnnouncementsHighTide Therapeutics Sets 2026 AGM to Approve Accounts, Board Slate and Share Issuance Mandate5M ago2511- Company AnnouncementsHighTide Therapeutics Strengthens Board With Appointment of Veteran Audit Chairman6M ago2511
Company AnnouncementsHighTide Therapeutics Details Board Composition and Committee Roles6M ago2511
Company AnnouncementsHighTide Therapeutics Grants HK$15 Million Connected-Party Loan to Founder-CEO6M ago2511Company AnnouncementsHighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results7M ago2511
Company AnnouncementsHighTide positions HTD1801 as potential foundational therapy for CKM diseases7M ago2511
- Company AnnouncementsHighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results7M ago2511
- Company AnnouncementsHighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA7M ago2511
- Company AnnouncementsHighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD18019M ago2511
Company AnnouncementsHighTide Therapeutics Names Veteran Cardiometabolic Leader Filip Surmont as Chief Medical Officer9M ago2511
Company AnnouncementsHighTide Therapeutics Sets Up Nomination Committee to Bolster Governance10M ago2511Company AnnouncementsHighTide Therapeutics Showcases Renal Benefits of HTD1801 at ASN Meeting12M ago2511